MAIA Biotechnology, Inc. Common Stock — Balance Sheet (NYSE:MAIA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Total assets 12.02 M7.57 M10.16 M9.7 M Total liabilities 3.51 M7.09 M6.52 M7.33 M Total equity 8.51 M477.51 K3.63 M2.38 M Total liabilities & shareholders' equities 12.02 M7.57 M10.16 M9.7 M Total debt ———— Net debt ————

News

MAIA Biotechnology Completes Enrollment Of Patients For Part C Of Phase 2 Study Of Ateganosine Sequenced With CPI Cemiplimab To Treat Non-Small Cell Lung Cancer

MAIA Biotechnology Files Resale Prospectus For 751,879 Shares Issued Under Clinical Trial Funding Agreement

MAIA Biotechnology Receives Regulatory Approval By The Spanish Agency For Medicines And Medical Devices And Portugal’s National Authority Of Medicines And Health Products To Begin Screening Patients For Its Ongoing Pivotal Phase 3 THIO-104 Clinical...

Microsoft plans to release its next-generation MAIA 300 AI chip in September

Microsoft: Azure Skies, Premium Altitude (NASDAQ:MSFT)

MAIA Biotechnology shares drop 29% on discounted stock offering

Vitoc Vlad, CEO of Maia Biotechnology, buys $10k in shares

Vlad Vitoc, Maia Biotech CEO, buys $79,848 in Maia stock

Vitoc Vlad buys MAIA biotechnology (MAIA) shares worth $79,848

Luput Cristian, director at Maia Biotechnology, buys $41,845 in shares

Smith Stan, MAIA Biotechnology director, buys $15,582 in shares

Luput Cristian, director at Maia Biotechnology, buys $9,785 in shares